The Contractility of Fibroblasts in a Collagen Lattice Is Reduced by Corticosteroids  by Coulomb, Bernard et al.
0022-202X/84/8204 -0341$02.00/0 
THE JOURNAl. OF INVESTIGATIVE DERMATOLOGY, 82:341 - 344, 1984 
Copyright © 1984 by The Williams & Wilkins Co. 
Vol. 82, No. 4 
Printed in U.S.A. 
The Contractility of Fibroblasts in a Collagen Lattice Is Reduced by 
Corticosteroids 
BERNARD COULOMB, PH.D., LOUIS DUBERTRET, M.D., EUGENE BELL, PH.D., AND RENE TOURAINE, M.D. 
Laboratoire d'Etu.de de l'Jnflamma.tion cu.tmu?e, Service de Dermatologie, Hopital Henri Mondor (BC, LD, RT), Crti teil, France, and Depart.ment 
of Biology, Massachusetts Institute of Technology (EB), Cambridge, Massachusetts, U.S.A. 
Normal human and rat skin fibroblasts, incorporated 
into a three-dimensional collagen lattice, were assayed 
for their ability to contract collagen fibrils. This capac-
ity is inhibited in a dose-dependent fashion by both 
dexamethasone and hydrocortisone. The inhibition is 
reversed when the corticosteroids are removed from the 
culture medium, but while the effect of hydrocortisone 
is almost entirely reversible, that of dexamethasone is 
not. 
Corticosteroids are members of a drug family widely used in 
human therapy as anti-inflammatory agents. Their biologic 
effects have been studied extensively. In particular, their effects 
on cell proliferation [1-3] and protein synthesis [4-6] have 
been investigated with monolayered fibroblasts, which have 
also been used to elucidate their mode of action [7 ,8]. 
The monolayered cell culture system, however, as a model 
for analyzing pharmacologic effects has severe limitations since 
the state of differentiation of cells such as fibroblasts is quite 
unlike that of cells in vivo. The differences have been attributed 
to t he absence of a matrix with which cells a re normally 
associated. 
Recently, a three-dimensional culture system, the contracted 
collagen lattice, has been developed [9], in which fibroblasts 
exhibit properties of membrane permeability and enzymatic 
activity quite different from those observed in cells grown as 
monolayer and similar to those observed in human dermis in 
vivo [10,11] . Moreover, the collagen lattice is a model which 
makes possible the quantitative study of contraction of fibrils 
by fibroblasts, a key function in wound healing. 
In this study, using the collagen lattice model we have com-
pared the effects of hydrocortisone and dexamethasone on the 
capacity of human and rat fibroblasts to contract tissue equiv-
alent lattices. 
MATERIALS AND METHODS 
Cell cul tures were established with fibroblasts from biopsies of adult 
human sk in obtained from breast plastic surgery or of adult Wistar rat 
in. The ce lls were propagated in cu lture medium [Earle's modified 
Eagle's medium (EMEM) for human cells, or Dulbecco's modified 
Eagle's medium (DMEM) for rat ce lls, Flow Labs] conta ining 10% 
feta l calf serum (Flow Labs), 100 lU/ml penicillin , 100 11g/ml strepto-
mycin (Flow Labs), a nd 2.5 J.lg/111 Fungizone (Squibb). The t issue-
culture flasks were kept. in an incubator at 37' C, in a C02 atmosphere (5 % with EMEM , 10% with DMEM). 
Corticosteroids used in this work were dexamethasone 21 phosphate 
(Merck Sharp & Doh me Chibret.) and hyd rocorti sone 21 hemisucci nate 
sodium salt (Roussel). Both compounds went into solution readily in 
the culture medium. 
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We seeded collagen lattices with fibroblasts from subconfluent or just confluent cultures. Cells were removed from flasks by trypsin 
treatment (0.05 % trypsin 1:250 and 0.02 % EDTA, Flow Labs). The 
cells were then washed with culture medium conta ining serum a nd 
suspended in cu lture medium with 10% feta l calf serum and antib iot ics. 
The lattices were prepared in 60-mm bacteriologic dishes as previously 
described (9,1 2,13]. Each dish contained 2.3 ml of concentrated medium 
(EMEM or DMEM) with antibiotics and corticosteroid, which was 
deleted from co ntrol dishes, 1.5 ml of collagen solu tion (1.5 mg/ ml), 
0.25 ml of 0.1 M NaOH , 0.45 ml of fe ta l calf serum, and 0.5 ml of 
EMEM or DMEM with 6 x JO'' ce lls/ ml suspended. Collagen was 
ext racted from rat tail tendons in acetic acid (1:1000). Corticosteroids 
were added to the concentrated culture medium just before lattices 
were cast. Concentrations of co rticosteroids in t he final volume were 
the following: for human fibroblasts 2 X 10-·l M to 20 X 10- ' M of 
dexamethasone, 2.5 x 10-·l M t.o 15 X 10- ·l M of hydrocortisone, and 
with rat. fibroblasts 2.5 X 10-n to 15 X 10-' M of eit her dexamethasone 
or hydrocorti sone. Three lattices were used for each concentration of 
corticosteroid in each experiment. Where indicated 1.0 11g/ml of cyto-
sine arabi noside (A ra-C, S igma) was added in t he medium to stop ce ll 
divis ion . Medium was renewed, or replaced by corticosteroid-free me-
dium, at 3 days and 7 days , in different experiments. When corticoste-
roid was removed, the medium was a lso replaced the day after the 
cha nge to be certa in t hat the concentration of corticosteroid was greatly 
reduced. The diameter of each lattice was regularly measured by placing 
the dish on a transparent. metric scale. The mean and the standard 
deviation of lattice diameter at each time point was calculated on the 
basis of measurements of at least 3 lattices. 
The influence on ce ll growth a nd toxicity of dexamethasone and 
hydrocortisone was determined on fibroblasts in monolayer. Cortico-
ste roids (15 x w-• M) were added, on day 0, to the medium used for 
25-cm' tissue culture flasks with 3 x 105 fibrob lasts per flask. Three 
fl asks were used for each t ria l. The medium was renewed on day 3. On 
day 7, ce lls were removed by trypsin and the number of live and dead 
ce lls determined by trypan-blue exclusion. The change in cell number 
in corticosteroid -contain ing medium was expressed as a percentage of 
the increase in cell number seen in controls. S imilar experiments were 
performed with 1.0 11g/ ml of Ara-C added in the medium. 
RESULTS 
Influence of Corticosteroids on the Contraction. of Collagen 
Lattices by Human Cells 
Both dexamethasone and hydrocortisone inhibited lattice 
contraction (Fig 1). By 1-3 days equilibrium was reached and 
no further contraction was observed. When cell divisions were 
stopped by 1.0 11g/ml Ara-C, t he contraction was not significa-
t ively modified in either corticosteroid-treated or control lat-
tices (Fig 1), suggesting that li ttle cell division occurs after cells 
are cast in the lattice [14]. 
At 2 X w-·l M dexamethasone with Ara-C, no inhibition of 
lattice contraction was observed. At 20 x w-·l M dexamethasone 
with Ara-C, the lattice contraction was completely inhibited; 
cells did not extend processes but remained rounded up, indi -
cating a toxicity of the dexamethasone at this concentration. 
Thus, to work in a range of concentrations where the inhibition 
of contraction is detectable and where no toxic effect could 
interfere, we chose concentrations between 2.5 x 10-·1 M and 
15 X 10- -l M for both dexamethasone and hydrocortisone. 
It is seen with both dexamethasone (Fig 2) and hydrocorti -
sone (Fig 3) that the extent of inhibition of lattice contraction 
is a function of corticosteroid concentration. In the range of 
concentrations studied, the effect on contraction, after equilib-
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F IG 1. Inhibi t ion of normal lattice cont raction (•) by dexametha-
sone 15 x 10- ·l M <•l or by hydrocorti sone 15 x 10-·l M (e). Same 
experiments with 1.0 11g/ml Ara-C added in t he medium of the control 
(0 ), or of the dexamethaso ne (0) or hydrocortisone (0 ) treated lattices. 
c .. tracti•" 
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Human Fibroblasts in Collagen Lattices 
Dexamethasone 
FIG 2. Dose-dependent inhibition of lattice contraction, in the pres-
ence of l.O 11g/ml Ara-C, by dexamethasone 15 X 10-·l M (e), 10 x 10- ·l 
M (T ), 2.5 x w-·l M <•l; control <•l. 
Human Fibroblasts in Collagen lattices 
Hydrocortiwne 
1 Oa~ 
FIG 3. Dose-dependent inhibition of lattice contraction, in presence 
of 1.0 11g/ml Ara-C, by hydrocortisone 15 x 10- ' M (e), 10 x 10-• M 
(T), 2.5 x 10- ' M <•l; control (•) . 
rium was reached, was linear and proport ional to concentration 
(Fig 4) . However, differences exist between hydrocortisone and 
dexamethasone: while the curve representing contraction val-
ues as a function of concentration of hydrocortisone can be 
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extrapolated to pass through the control value at zero concen -
tration, that representing the relationship for dexamethasone 
cannot. 
The inhibition of contraction was reversible but to different 
degrees depending on the agent. Lattice diameter remained 
constant if corticosteroid was maintained in the culture me-
dium but was decreased, t hat is, contractility was enhanced 
when the corticosteroid was removed. When dexamethasone ui 
x 10_,, M was removed from the medjum either at 3 or 7 days , 
the lattices underwent a second phase of contraction and 
reached a new plateau; however, the extent of contraction was 
not as great as that of the control (Fig 5). With hydrocortisone 
(15 X 10-·l M), however, the recovery obtained was nearly 
complete, with the djarneter of the lattice reaching a value 
simila r to that of the control (Fig 6), especially when it was 
washed out at 3 days. 
As previously described [9], the control lattice without cells 
did not contract. 
Influence of Corticosteroid on the Contraction of Collagen 
Lattice:; by Rat Cells 
Similar results were obtained with rat fibroblasts. Either 
with dexamethasone or with hydrocortisone we observed com-
parable dose-response effects (Fig 7). The concentra tions re-
quired to inhibit lattice contraction were lower for rat cells 
t han those needed for human fibroblasts. Inhibition was de-
tected with doses as low as 2.5 X 10- " M dexamethasone or 
hydrocortisone. 
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F1r. 4. Dose-dependent inhibition of lattice contraction in the pres-
ence of 1.0 11g/m l Ara-C at 7 days. At. the concentrations 2.5 x 10- 4 M, 
10 x 10- • M, a nd 15 X 10- ' M, of dexamethasone <•l or hydroco rt isone 
(e) the inhibition is linea r. Control <•l. The dotted lines are extrapo-
lations Lo zero concentration. 
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FIG 5. Inhibi t ion of lattice contraction by dexamethasone 15 X 10- 4 
M in the presence of 1.0 11g/ml Ara-C. With dexamethasone present 
(T) or removed (0-+) at 3 days (0) or at 7 days <•l; control (•). 
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F IG 6. l nhibition of lattice contraction by hydrocortisone 15 X 10- ' 
M in t he presence of 1.0 ,,g/m l Ara-C. With hydrocortisone present ('9') 
or removed([].....) at 3 days (0) or at 7 days (A); control (+). 
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F IG 7. Dose-dependent inhibition of lattice contraction, in the pres-
ence of 1.0 ,,g/ml Ara-C by dexamethasone or hydrocortisone 10 X 10- ·l 
M (e), 2.5 X 10-·l M ('9'), 2.5 X 10- G M (A); control (+). 
Cell Morphology in Collagen Lattices 
In control lattices, fib roblasts are well separated from each 
other, t hey are elongated and d~splay ge nerally 2 or 3 long 
processes in contact with the collagen fibers . When dexameth-
asone or hydrocortisone, at a concentration of 15 x 10-·1 M 
(with or without Ara-C), is added to t he medium, no cha nge in 
ce ll morphology or cell orientation was detected wit h phase 
contrast microscopy. 
Influence of Corticosteroid on Viability and Growth Rate of 
Cells in Monolayer 
In monolayer, t he growth of t he huma n and rat fibroblasts 
was s lowed when either dexamethasone or hydrocortisone (15 
x w-·l M) was added in t he cu lture medium. Both agents 
reduced cell number to about 30% of that of t he control. 
In t he presence of 1.0 ,ug/ml Ara-C, no significant difference 
in t he ce ll number (human fibroblasts) was observed between 
dexamethasone or hydrocortisone (15 X w-·l M) treated cul tures 
and controls. Ce ll mortality measured by t rypan-blue staining 
was found to be less than 1.5% in both experimental and control 
cultures. 
DISCUSSION 
Both dexamethasone and hydrocortisone inhibit fibroblast 
contraction of collagen lattices. The inhibit ion by both corti-
costeroids is linearly dose-dependent in t he range of concentra-
tions studied. The fact t hat the curve of concentration vs 
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contraction cou ld be extrapolated through the control value, at 
zero concen tration, for hydrocortisone but not for dexametha-
sone, cou ld mean that a threshold dose exists for the latter and 
not for the forme r. T his threshold could reflect an exclusion 
mechanism [15) at low concentrations of dexamethasone. An-
other difference exists between the two drugs: while t he effect 
of hydrocortisone is a lmost entirely reversible, that of dexa-
methasone is not. This difference may have two explanations 
both of which may app ly: the first is that the cell membrane 
may be less permeable to dexamethasone than to hydrocorti-
sone for the flow into and out of the cell; t he second is that 
binding of the drugs to glucocorticoid receptors within the cell 
is more efficient for dexamethasone. 
Since t he rate and extent of lattice cont raction are directly 
dependent on cell number at a fixed concentration of collagen 
(14], and since cell growth is affected by dexamethasone and 
hydrocortisone when fibroblasts are grown in monolayer, it was 
important to establish conditions t hat ruled out the possibility 
t hat the drug-treated lattices had fewer cells. Despite t he fact 
t hat cell division ceases soon after cells are incorporated into a 
collagen lattice, Ara-C was used t hroughout to block DNA 
synthesis. At a concentration of 1.0 ,ug/ml, t he block to cell 
division was complete and, in the presence of Ara-C, the highest 
concentratio n of corticosteroid used (15 X w-" M) does not 
reduce t he number of living cells in the culture as compared 
with that of the control. The number of trypan blue-stained 
cells was monitored and seen to be the same (about 1.5%) in 
t he p resence or absence of corticosteroids. In the lattices, at 
the level of t he light microscope no obvious differences in cell 
morphology were observed. Fibroblasts in treated lattices were 
in general elongated a nd spindle shaped, as t hey appeared in 
untreated lattices, but we do not rule out more subtle effects of 
the co rt icosteroids on ce ll cytostructure. 
We have no explanation for the greater sensitivity of rat 
fibroblasts to dexamethasone or to hydrocortisone as compared 
with human cells. Similar differences exist among human cell 
strains [1) and might be attributed to differences in cell perme-
ability. 
While others have shown that cell division fl -3) and biosyn-
thesis of secreted matrix materials such as collagen [ 4,5], hy -
aluronic acid [ 4,6], and sulfated glycosaminoglycans [ 4) are all 
decreased by cort icosteroids, we provide evidence for a more 
general effect, that is, a reduced capacity of fibroblasts to collect 
and compact co llagen fib rils. These activities, and the conse-
quent syneres is, are responsible for the decrease in lattice 
diameter which t he assay measures. Our finding points to other 
possible sites of action of dexamethasone and hydrocortisone. 
Targets might be the actomyosin engine needed to contract 
extended podia I processes, the binding s ites t hrough which cells 
attached to collagen either directly or through an intermediate 
such as fibronecti n, or the metabolic machinery which provides 
the energy necessary for contraction. T hus, as corticoid potency 
can be evaluated in other assays such as vasoconstrictor action 
[16] or suppression of experimenta l inflammation [17], the 
inhibition of t he lattice contraction may serve as a useful 
complementary test. 
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